Zenas BioPharma (ZBIO) EBT (2023 - 2026)
Zenas BioPharma's (ZBIO) quarterly EBT came in at -$81.0 million in Q1 2026, down 139.76% year-on-year from $203.7 million in Q1 2025, and up 67.74% quarter-over-quarter from -$251.0 million in Q4 2025.
Zenas BioPharma (ZBIO) EBT (2023 - 2026) Analysis & Trends
Zenas BioPharma's EBT history runs 4 years deep, the most recent figure standing at -$81.0 million for Q1 2026.
- On a quarterly basis, EBT fell 139.76% year-over-year to -$81.0 million in Q1 2026; TTM through Mar 2026 was -$435.7 million, a 168.07% decrease from a year earlier, with the FY2025 full-year figure at -$388.5 million, down 148.16% from the prior year.
- EBT rose to -$81.0 million in Q1 2026 per ZBIO's latest filing, from -$251.0 million in the prior quarter.
- Across five years, EBT topped out at $35.6 million in Q3 2023 and bottomed at -$251.0 million in Q4 2025.
- The 4-year median for EBT is -$38.6 million (2024), against an average of -$56.7 million.
- Biggest YoY gain for EBT was 21.5% in 2025; the steepest drop was 381.13% in 2025.
- Year by year, EBT stood at -$32.9 million in 2023, then slumped by 58.77% to -$52.2 million in 2024, then sank by 381.13% to -$251.0 million in 2025, then jumped by 67.74% to -$81.0 million in 2026.
- Per Business Quant, the three latest ZBIO EBT figures stand at -$81.0 million (Q1 2026), -$251.0 million (Q4 2025), and -$51.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | -80.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.99 Mn |
| Dec 31, 2025 | -251.03 Mn |
| Sep 30, 2025 | -51.50 Mn |
| Jun 30, 2025 | -52.20 Mn |
| Mar 31, 2025 | -33.78 Mn |
| Dec 31, 2024 | -52.18 Mn |
| Sep 30, 2024 | -38.61 Mn |
| Jun 30, 2024 | -37.98 Mn |
| Mar 31, 2024 | -27.80 Mn |
| Dec 31, 2023 | -32.86 Mn |
| Sep 30, 2023 | 35.62 Mn |